Leptin and the treatment of obesity: its current status

Author： Lee D.W.   Leinung M.C.   Rozhavskaya-Arena M.   Grasso P.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.440, Iss.2, 2002-04, pp. : 129-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Orlistat: its current status as an anti-obesity drug

By Ballinger A.   Peikin S.R.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 109-117

Elsevier

Access to resources Recommend Favorite

Sibutramine: current status as an anti-obesity drug and its future perspectives

By Sharma Bikash   Henderson David C  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 12, 2008-08 ,pp. : 2161-2173

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological treatment of obesity in children and adolescents: current status and perspectives

By Catoira Natalia   Nagel Mara   Di Girolamo Guillermo   Gonzalez Claudio D  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 18, 2010-12 ,pp. : 2973-2983

Informa Healthcare

Access to resources Recommend Favorite

Current Status of Antipsychotic Treatment

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 2, 2002-04 ,pp. : 123-128

Bentham Science Publishers

Access to resources Recommend Favorite

A Perspective on the Current Strategies for the Treatment of Obesity

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 5, 2004-10 ,pp. : 341-356

Bentham Science Publishers

Access to resources Recommend Favorite